Press Release: Adverum : INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc.
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adverum Biotechnologies, Inc. (Adverum or the Company) (NASDAQ: ADVM). Such investors are...
Read full article »
Adverum is a California-based biotechnology company that develops and commercializes gene therapeutics for the treatment of eye diseases.
Read more